Thalassaemia: A Silent Killer in Many Parts of the World

Introduction

Thalassaemia is a group of inherited blood disorders that affect the body’s ability to produce hemoglobin, a protein found in red blood cells that carries oxygen to the body’s tissues. Individuals with this disorder have abnormal hemoglobin production, which can cause a range of health problems. In this blog post, we will explore the causes, symptoms, and treatments for thalassaemia, as well as its impact on individuals and communities. World Thalassaemia Day is observed on May 8th every year to raise awareness about thalassaemia and its impact on individuals and families.

Types of Thalassaemia

1. Beta : This type of thalassemia occurs when the body is unable to produce enough beta-globin protein, which is needed to make hemoglobin. Beta thalassemia can be further divided into two subtypes: beta thalassemia minor and beta thalassemia major.
2. Alpha : Alpha thalassemia occurs when the body is unable to produce enough alpha-globin protein, which is needed to make hemoglobin. This type of thalassemia can also be divided into several subtypes, including alpha thalassemia minor and Hb Bart’s hydrops fetalis.
3. Intermedia: This is a milder form of thalassemia that is not as severe as thalassemia major. Individuals with thalassemia intermedia may not require regular blood transfusions, but they may still experience symptoms such as anemia and fatigue.
4. Major: This is the most severe form of thalassemia, which requires regular blood transfusions to manage the symptoms. Individuals with thalassemia major may also require other treatments, such as iron chelation therapy to manage iron overload.
5. Hemoglobin E : This is a type of thalassemia that occurs when an individual has inherited both a hemoglobin E mutation and a beta thalassemia mutation. Hemoglobin E thalassemia can vary in severity depending on the specific mutations involved.
6. Hemoglobin H Disease: This is a type of alpha thalassemia that occurs when an individual has inherited three alpha-globin gene mutations. Hemoglobin H disease can cause mild to moderate anemia, as well as other symptoms such as fatigue and jaundice.

Causes of Thalassaemia

Thalassaemia is caused by mutations in the genes that control the production of hemoglobin. Hemoglobin is made up of four protein subunits, two alpha globin chains and two beta globin chains. In thalassaemia, mutations in the genes that control the production of these subunits can result in reduced or absent hemoglobin production. There are two main types of thalassaemia: alpha thalassaemia and beta thalassaemia.

Alpha thalassaemia occurs when there is a mutation in one or more of the alpha globin genes. Beta thalassaemia occurs when there is a mutation in one or both of the beta globin genes. Individuals who inherit one mutated gene from a parent are carriers of thalassaemia and are typically asymptomatic. However, individuals who inherit two mutated genes, one from each parent, will develop thalassaemia.

Symptoms of Thalassaemia

The symptoms of thalassaemia can vary depending on the severity of the condition. Individuals with alpha thalassaemia may have mild or no symptoms, while those with beta thalassaemia can experience a range of symptoms from mild to severe.

The most common symptoms of thalassaemia include fatigue, weakness, shortness of breath, and pale skin. In more severe cases, individuals may experience jaundice, a condition where the skin and eyes appear yellow due to high levels of bilirubin in the blood. They may also develop bone deformities, especially in the face and skull, and an enlarged spleen or liver.

Diagnosis of Thalassaemia

Thalassaemia is typically diagnosed through a blood test that measures the amount of hemoglobin in the blood. A low hemoglobin level may indicate the presence of thalassaemia. In addition, a genetic test can be used to identify mutations in the genes responsible for hemoglobin production.

Treatment of Thalassaemia

The treatment of thalassaemia depends on the severity of the condition. Mild cases of thalassaemia may not require treatment, while more severe cases may require lifelong management.

Individuals with thalassaemia may require blood transfusions to increase their hemoglobin levels. These transfusions can be given on a regular basis, such as every few weeks, to maintain normal hemoglobin levels. However, frequent transfusions can cause iron overload in the body, which can lead to organ damage.

To prevent iron overload, individuals with thalassaemia may require chelation therapy, a treatment that removes excess iron from the body. Chelation therapy can be given orally or through an injection.

In addition, individuals with thalassaemia may require folic acid supplements to support red blood cell production. They may also require bone marrow transplants, which can provide a cure for thalassaemia in some cases.

Impact of Thalassaemia

Thalassaemia can have a significant impact on individuals and communities. In addition to the physical symptoms of the condition, individuals with thalassaemia may experience social and emotional challenges.

In some cultures, there is a stigma associated with thalassaemia, which can lead to discrimination and isolation for affected individuals and families. In addition, the financial burden of treatment can be significant, particularly in areas with limited access to healthcare resources.

Thalassaemia is also a significant public health issue in many parts of the world, particularly in countries in the Mediterranean region, South Asia, and Southeast Asia. In these regions, the prevalence of thalassaemia is high due to a high rate of consanguineous marriages, where individuals who are closely related marry and have children.

Prevention of Thalassaemia

Prevention of thalassaemia is an important public health issue. In areas with high rates of thalassaemia, genetic counseling and screening programs can help identify carriers of the condition and prevent affected individuals from having children with thalassaemia.

In addition, pre-implantation genetic diagnosis (PGD) is a technique that can be used to screen embryos for thalassaemia before they are implanted in the uterus. This can help prevent the birth of children with thalassaemia in families with a history of the condition.

Conclusion

Thalassaemia is a complex genetic disorder that can have a significant impact on individuals and communities. Understanding the causes, symptoms, and treatments of thalassaemia is essential for healthcare providers, policymakers, and affected individuals and families. Prevention of thalassaemia through genetic counseling, screening, and other interventions can help reduce the prevalence of the condition and improve the quality of life for affected individuals and their families.